Home » Uncategorized » BI names new chairman of managing directors

BI names new chairman of managing directors

Monday, November 9, 2015

After 24 years of service to Boehringer Ingelheim (BI), Professor Andreas Barner will retire as chairman of the board of managing directors on June 30, 2016, and will move to the company’s shareholders committee.

After completing his doctorate in medicine and mathematics, Barner joined BI in 1992 as head of the medical division. He became a member of the board of managing directors in 1999, and has been chairman since 2009. Christian Boehringer, chairman of the shareholders committee, thanked Barner for his many years of wide-ranging service, during which time he realigned the company’s research, development and medical activities. He was particularly instrumental in further consolidating and expanding Boehringer Ingelheim’s independence as a family-owned company.

He will be succeeded by Hubertus von Baumbach, whom the shareholders have appointed as the new chairman of the board of managing directors. Hubertus von Baumbach completed a banking apprenticeship and the first and second German state legal examinations before going on to receive an M.B.A. from MIT in Cambridge, Mass. He has been a member of the board of managing directors since 2009 and is head of the corporate board division finance. Following periods at Roche in the U.S. and at BI in Canada, he performed various functions in the finance division at BI in Germany.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!